We added the following clinical trials to Metastatic Trial Search for May 2024. To see all clinical trials, please visit Metastatic Trial Search.
ER or PR Positive Trials
- BTX-A51 Targeted Therapy for Advanced ER+, HER2- Breast Cancer
- Vepdegestrant Hormone Therapy with PF-07220060 CDK4 Inhibitor for Advanced ER+ or ER Low, HER2- Breast Cancer
HER2 Positive Trials
Triple Negative Trials
- LY4101174 ADC for Advanced Triple Negative Breast Cancer
- CTX-8371 Bispecific Antibody for Advanced Triple Negative Breast Cancer
- NKT3447 CDK2 Inhibitor for Advanced Triple Negative or HR+, HER2- Breast Cancer
- KFA115 Immunotherapy Alone and With Pembrolizumab for Advanced Triple Negative Breast Cancer
Other Stage IV Trials
- Ommaya Reservoir Placement During Biopsy to Study Biomarkers for People With Brain Metastases
- NUV-1511 Targeted Therapy for Advanced Breast Cancer
- Datopotamab Deruxtecan ADC for HER2- Breast Cancer That Spread to the Brain or Leptomeninges
Last Modified on April 30, 2024